Growth Metrics

Idexx Laboratories (IDXX) Cost of Revenue (2016 - 2026)

Idexx Laboratories has reported Cost of Revenue over the past 17 years, most recently at -$568.1 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 248.09% year-over-year to -$568.1 million; the TTM value through Dec 2025 reached $127.2 million, down 87.95%, while the annual FY2025 figure was $643.5 million, 57.62% down from the prior year.
  • Cost of Revenue for Q4 2025 was -$568.1 million at Idexx Laboratories, down from $159.2 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $1.0 billion in Q4 2023 and troughed at -$568.1 million in Q4 2025.
  • A 5-year average of $185.3 million and a median of $160.1 million in 2025 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: surged 311.57% in 2023 and later crashed 248.09% in 2025.
  • Year by year, Cost of Revenue stood at -$302.4 million in 2021, then tumbled by 63.63% to -$494.8 million in 2022, then surged by 311.57% to $1.0 billion in 2023, then tumbled by 63.36% to $383.6 million in 2024, then crashed by 248.09% to -$568.1 million in 2025.
  • Business Quant data shows Cost of Revenue for IDXX at -$568.1 million in Q4 2025, $159.2 million in Q3 2025, and $161.1 million in Q2 2025.